of extraction, and the degree of antileukemia responses due to therapy, and the antileukemia immune responses that may be occurring in the patient (see below). Just as important are the clinical issues, 4 that is, it is premature to draw firm conclusions about whether a patient requires reinstatement of therapy or discontinuance of therapy based solely on quantitative RT-PCR results.
The idealized experiment listed in the table shown in Rawer et al 2 reflects the fact that Poisson distribution is a truism. However, patient samples have day-to-day variances that affect the levels of transcripts/assay tube that are often uncontrollable (as described above).
Another issue relates to the sensitivity of these quantitative PCR assays. Nested PCR for BCR-ABL RNA can detect a single leukemia cell in a background of 10e5 to 10e6 normal cells. A volume of 10-40 ml of blood (or several ml of marrow) represents only a very small fraction of the total blood volume. Patients in clinical remission might have a preponderance of blood cells that lack BCR-ABL transcripts. Thus, a negative result for BCR-ABL transcripts could mean either that value is below the limit of detection given the limitation of the sampling (eg less than 40 ml blood) or the assay limitation itself. A patient with a negative value might still have a significant population of BcrAbl positive blood cells either in circulation, in the marrow or in various tissues (eg spleen). Assay limitations may be reduced as the technology improves. However, sampling limitations will be difficult to overcome.
Lastly, the role of immune surveillance in the control of CML is not well understood. Many believe that immune-based antileukemia effects are significant, especially in patients with minimal residual disease. 4 Importantly, these immune surveil- We thank Arlinghaus and his co-workers for their detailed reply and the additional information. 1 However, to clarify the point, we do not share the common belief that 75 cycles are more sensitive than 40 or 45. This assumption may be correct for end point techniques but not for real-time PCR.
If only a single template is present in a real-time PCR, the reaction will become undoubtedly visible after a given number of cycles as an amplification plot. If there is no template, it will not. Unlike in end point techniques that are based on simple fluorescent signals, there is nothing in between 1 and 0 copies, as it is possible to distinguish an amplification plot and a nonamplification plot by regarding its slope. 2 The exact cycle number needed depends on the PCR efficiency that can easily be determined in real-time PCR. Typically it varies around 40.
In their original paper, the group of Arlinghaus stated 'that nested, competitive RT-PCR [should] be used to determine BCR-ABL/ABL transcript ratios at low level transcript values or especially when real-time analysis are negative'. 3 This conclusion was based on samples that were scored negative in real-time PCR but positive in competitive PCR. They did not, however, present data to clarify whether real-time PCR was false-negative or nested PCR was false-positive.
To address this question experimentally, we reasoned that if sensitivity of real-time PCR was near 100%, we would be able to Correspondence confirm experimentally the Poisson distribution of templates even at very low copy numbers. We did not question the mere existence of Poisson distribution, but used it to predict the number of copies to be expected. The data we presented met these predictions, thus proving not only a high sensitivity, but also a high precision of the real-time PCR. We therefore conclude that real-time PCR comes close to the limit of sensitivity and that false-negative results are very unlikely. Reversely, a careful reevaluation of the applied nested PCR may be desirable. In response to Rawer et al, 1 we maintain our position that realtime PCR has a less positive detection rate for BCR-ABL transcripts than nested, competitive PCR, as described in Guo et al. 2 Briefly, there are two ways to increase the positive detection rate: (1) increase the sample size and (2) repeat the test multiple times. Regarding nested PCR, two sets of different primers (the second set nested within the amplimer of the first set) are used in a two-step reaction. Therefore, the sample size is increased by a factor of two. In comparison, real-time PCR uses just one set of primers in a one-step reaction.
Whether real-time PCR and nested PCR values may have false-negative or false-positive values, we submit the following. Most, if not all, chronic myeloid leukemia patients will never be without BCR-ABL transcripts in their tissues and blood, no matter how thorough the treatment. At issue is whether a given sample of RNA from blood/marrow is truly negative. We chose a system of three replicate analyses, which has a 95% chance to detect at least one positive score when the expected value is 1. Also in every patient assay, we included a true negative control, and only included negative values from patient samples that have an acceptable level of intact RNA (as measured by c-ABL transcripts).
Regarding the paragraph 'We reasoned that if sensitivityy', we submit the following. In their previous response, Rawer et al presented a table that showed the observed mean from eight replicates was similar to the expected value, and the variances were similar to the observed mean (in fact, sample variances were greater than the sample mean in three out of four cases).
Although this may confirm that the outcomes follow the Poisson distribution, this does not imply that the sensitivity of real-time PCR is near 100%. For example, let us suppose that the expected value is 1 and we have observed 0, 0, 0, 0, 1, 2, 3, 4. The observed mean is 1.25, the sample variance is 2.5, and the index of dispersion R(t) is 2. Sensitivity (scoring positive) from these observations is only 50%. The important issue is the accuracy of an assay with a limited number of replicates for the detection of positive cases (not means or variances). In our study, three replicates were used, for reasons explained above. Eight replicates are not practical, as we have discussed in our previous response. 
